Granules India Ltd (GRAN)

Currency in INR
699.70
-4.85(-0.69%)
Closed·
GRAN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
690.00722.50
52 wk Range
430.70730.80
Key Statistics
Bid/Ask
695.30 / 699.70
Prev. Close
704.55
Open
705
Day's Range
690-722.5
52 wk Range
430.7-730.8
Volume
1.65M
Average Volume (3m)
1.02M
1-Year Change
53.5103%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GRAN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high P/E ratio relative to near-term earnings growth

Granules India Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Apr 29, 2026
EPS / Forecast
7.60 / 5.40
Revenue / Forecast
14.71B / 14.29B
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 24.47%
Dividend Yield
0.21%
Industry Median 0.76%
Annualized payout
1.50
Paid unevenly
5-Years Growth
+8.45%
Growth Streak

GRAN Income Statement

Compare GRAN to Peers and Sector

Metrics to compare
GRAN
Peers
Sector
Relationship
P/E Ratio
31.8x28.3x−0.5x
PEG Ratio
2.290.450.00
Price/Book
4.4x3.8x2.6x
Price / LTM Sales
3.4x4.3x3.2x
Upside (Analyst Target)
−0.8%14.1%47.8%
Fair Value Upside
Unlock3.9%6.7%Unlock

Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationally. It offers paracetamol, metformin, guaifenesin, and methocarbamol, as well as prescription and over-the-counter products. The company also develops and manufactures tablets, capsules, press fits, oral solutions, suspensions, and powder for oral solutions. In addition, it provides development and manufacturing solutions for peptides, peptide fragments, and amino acid derivatives. The company offers its products in various therapeutic categories, including antiretroviral, anti-depressant, antihistamine, anti-diabetic, anti-cancer, multiple sclerosis, anti-thrombocytopenia, anti-ulcer, anti-convulsant, mucolytic/expectorant, anti-hypertensive, muscle relaxant, NSAIDs, anti-fibrotic, and anti-microbial, as well as anti-arrhythmic, CNS stimulant, anti-diarrheal, antihypertensive, uterine stimulant, chelating agent, mineral supplements, CNS depressant, PDE inhibitor, antispasmodic, and anti-viral. Granules India Limited was incorporated in 1984 and is headquartered in Hyderabad, India.

Employees
4066
Market
India

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
33.69M13.60%23.57B
Other Institutional Investors
39.90M16.10%27.91B
Public Companies & Retail Investors
174.21M70.30%121.89B
Total
247.8M100.00%173.38B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Life Insurance Corporation of India5.22%12,939,5709,053,817
SBI Life Insurance Company Limited3.28%8,117,0665,679,511

People Also Watch

1,095.75
NATP
+0.20%
5,266.40
CUMM
-0.41%
1,530.90
IPCA
-0.73%
1,100.95
LAUL
-0.47%

FAQ

What Is the Granules India (GRAN) Stock Price Today?

The Granules India stock price today is 699.70 INR.

What Stock Exchange Does Granules India Trade On?

Granules India is listed and trades on the India National Stock Exchange.

What Is the Stock Symbol for Granules India?

The stock symbol for Granules India is "GRAN."

Does Granules India Pay Dividends? What’s The Current Dividend Yield?

The Granules India dividend yield is 0.21%.

What Is the Granules India Market Cap?

As of today, Granules India market cap is 173.27B INR.

What Is Granules India's Earnings Per Share (TTM)?

The Granules India EPS (TTM) is 24.47.

When Is the Next Granules India Earnings Date?

Granules India will release its next earnings report on Apr 30, 2026.

From a Technical Analysis Perspective, Is GRAN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Granules India Stock Split?

Granules India has split 1 times.

How Many Employees Does Granules India Have?

Granules India has 4066 employees.

What is the current trading status of Granules India (GRAN)?

As of May 02, 2026, Granules India (GRAN) is trading at a price of 699.70 INR, with a previous close of 704.55 INR. The stock has fluctuated within a day range of 690.00 INR to 722.50 INR, while its 52-week range spans from 430.70 INR to 730.80 INR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.